1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1.Drivers
3.2.2.Restraints
3.2.3.Opportunities
3.2.4.Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for France Molecular Diagnostic Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in France Molecular Diagnostic Market
4. France Molecular Diagnostic Market
by Device
4.1. Polymerase Chain Reaction (PCR)
4.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
4.3. DNA Sequencing & Next-Generation Sequencing (NGS)
4.4. DNA Microarray
4.5. Others
5. France Molecular Diagnostic Market
by Application
5.1. Infectious Diseases
5.1.1. Hepatitis
5.1.2. HIV
5.1.3. CT/NG
5.1.4. Other
5.2. Oncology
5.2.1. Breast Cancer
5.2.2. Lung Cancer
5.2.3. Prostate Cancer
5.2.4. Other
5.3. Genetic Tests
5.4. Other
6. France Molecular Diagnostic Market
by End User
6.1. Hospital & Academic Laboratories
6.2. Reference Laboratories
6.3. Other
7. Company Profiles
7.1. Company 1
7.2. Company 2
7.3. Company 3
7.4. Company 4
7.5. Company 5
1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1.Drivers
3.2.2.Restraints
3.2.3.Opportunities
3.2.4.Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for France Molecular Diagnostic Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in France Molecular Diagnostic Market
4. France Molecular Diagnostic Market
by Device
4.1. Polymerase Chain Reaction (PCR)
4.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
4.3. DNA Sequencing & Next-Generation Sequencing (NGS)
4.4. DNA Microarray
4.5. Others
5. France Molecular Diagnostic Market
by Application
5.1. Infectious Diseases
5.1.1. Hepatitis
5.1.2. HIV
5.1.3. CT/NG
5.1.4. Other
5.2. Oncology
5.2.1. Breast Cancer
5.2.2. Lung Cancer
5.2.3. Prostate Cancer
5.2.4. Other
5.3. Genetic Tests
5.4. Other
6. France Molecular Diagnostic Market
by End User
6.1. Hospital & Academic Laboratories
6.2. Reference Laboratories
6.3. Other
7. Company Profiles
7.1. Company 1
7.2. Company 2
7.3. Company 3
7.4. Company 4
7.5. Company 5